凝固-繊維分解系が呼吸道と肺の改造に果たす役割
Hajime Fujimoto1, Esteban C Gabazza2
1Department of Pulmonary and Critical Care Medicine, Faculty and Graduate School of Medicine, Mie University, Japan.
Respiratory investigation
|August 30, 2025
まとめ
血液の凝固と凝固分解を制御している. 呼吸器の調節不良は肺の改造に寄与しますが,全身の抗凝固剤は限られた臨床効果を示しています.
科学分野:
- 生物化学
- 生理学
- 肺科
背景:
- 凝固と繊維分解は,血静性,血管修復,病原体防御を調節する異なるが相互に関連したシステムです.
- 繊維解析系はプラズミンを介して血栓を溶解し,様々な生理学的反応に影響を与えます.
- 肺改造は病気や環境要因によって引き起こされる 病的な肺組織の変化を伴うものです
研究 の 目的:
- 凝固と繊維分解が 呼吸道と肺の再構築に 果たす役割を調べる
- 臨床環境における現在の抗凝固剤療法の限界を調査する.
- 新しくターゲットを絞った 抗凝固剤の必要性を強調する
主な方法:
- 凝固,繊維分解,肺改造に関する既存の文献のレビュー.
- 血液静止系と肺病理の相互作用の分析
- 抗凝固剤療法における臨床的翻訳課題の評価
主要な成果:
- 呼吸道における血栓形成状態や 繊維分解機能障害は 肺の再構築を促す可能性があります
- 従来の抗凝固剤は動物モデルでは有望ですが,ヒト試験では有効性が限られています.
- 全身の抗凝固薬は出血のリスクが大きい.
結論:
- 凝固-繊維分解軸の複雑で二重な役割は,治療上の課題に寄与する.
- 肺改造の効果的かつ安全な治療には,標的型の抗凝固薬が必要である.
- 肺疾患における凝固と繊維分解のメカニズムに関するさらなる研究が必要である.
関連する概念動画
Clot Retraction and Fibrinolysis
6.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
Phases of Wound Repair
6.3K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
6.3K
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K


